Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Vitamin D in COVID-19
NCT04525820Completed
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing High Dose Vitamin D with Placebo (2 arms). Primary endpoint: Length of hospitalization. Started Dec 2020; status: completed.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04525820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04525820.